Latest News

The African Pooled Procurement Mechanism, led by the Africa Centres for Disease Control and Prevention, is designed to help Member States aggregate demand for medicines, vaccines, diagnostics, and other essential medical supplies.

Under this agreement, CellSave Arabia will act as the exclusive provider of cord blood, cord tissue, placental tissue, cord vessel, and amnion preservation services.

The approval adds a new option in the growing IL-17 inhibitor class and strengthens the company’s dermatology portfolio.

The development comes nearly two decades after the first human genome draft was completed in 2001 and a decade after Africa’s first human genome sequencing effort in South Africa in 2013.

The investment forms part of the company’s broader plan to spend US$55 billion on expanding its domestic manufacturing footprint through 2029.

The deal combines acquisition with a concurrent private placement of up to US$64 million in gross proceeds before expenses, strengthening development funding.

Scientia Vascular develops advanced access products designed to improve simplicity and precision during neurovascular interventions.

The care model integrates internationally recognised diagnostic frameworks such as ADOS for autism assessment, WISC for cognitive evaluation, and Conners Rating Scales for ADHD screening.

The designation highlights Abu Dhabi’s expanding role in global health security, particularly in strengthening systems that detect, track, and respond to infectious disease threats.

The partnership grants Lilly global rights to AlzeCure’s preclinical small-molecule candidate, ACD680, which targets the biology of Alzheimer’s disease.